Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

A group of advisors to the Centers for Disease Control and Prevention (CDC) voted 5-2 to recommend a new shot that can prevent serious sickness and death from respiratory syncytial virus ... in the ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering their first RSV season.

A LARGE-scale genomic surveillance study in France has found that resistance to nirsevimab, a monoclonal antibody used to prevent respiratory syncytial virus (RSV) in infants, remains rare despite ...

HMPV is similar to a virus that is better known in the United States — respiratory syncytial virus, or R.S.V. It causes symptoms much like those associated with flu and Covid, including cough ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential resistance mutations.

Stephanie Soucheray, MA Topics Respiratory Syncytial Virus (RSV) FotoDuets / iStock A new study in The Lancet Infectious Diseases describes the genotypic and phenotypic characteristics of respiratory ...